Literature DB >> 15698874

Current indications for neuromodulation.

Firouz Daneshgari1, M Louis Moy.   

Abstract

Neuromodulation is becoming a part of the clinical armamentarium for treatment ofa variety of lower urinary tract conditions. Its increased usage stems from the needs of patients who have exhausted all other therapeutic options. Currently, neuromodulation may consist of the use of nerve stimulation and injectable therapies. This article concentrates on nerve stimulation.

Entities:  

Mesh:

Year:  2005        PMID: 15698874     DOI: 10.1016/j.ucl.2004.09.009

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

1.  Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents.

Authors:  Farzaneh Sharifiaghdas
Journal:  World J Urol       Date:  2019-03-12       Impact factor: 4.226

2.  Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM).

Authors:  Karl-Dietrich Sievert; Udo Nagele; Juergen Pannek; Daniel Engeler; Markus Kuczyk; Arnulf Stenzl
Journal:  World J Urol       Date:  2007-10-03       Impact factor: 4.226

3.  Bladder dysfunction in diabetes mellitus.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  Front Pharmacol       Date:  2010-11-16       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.